Insider trades

Versant Ventures IV, 10% Owner of Tempest Therapeutics TPST, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/08/12.

Versant Ventures IV

10% Owner
First filing
23/01/04
Trades
27 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
24/08/12

Trading activity

Transactions

Trade type
TPST
Open-market sale24/08/08–24/08/1224/08/12787,999 sh2 trades$1.23avg.$966,798.9−79.0%